PILL:NYE-Direxion Daily Pharmaceutical & Medical Bull 3X Shares ETF (USD)

ETF | Trading--Leveraged Equity |

Last Closing

USD 7.45

Change

+0.24 (+3.33)%

Market Cap

N/A

Volume

0.01M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-03-05 )

Largest Industry Peers for Trading--Leveraged Equity

Symbol Name Price(Change) Market Cap
SOXL Direxion Daily Semiconductor B..

+1.30 (+6.30%)

USD 9.27B
QLD ProShares Ultra QQQ

+2.62 (+2.62%)

USD 8.27B
FNGU MicroSectors FANG+ Index 3X Le..

N/A

USD 8.18B
SSO ProShares Ultra S&P500

+1.90 (+2.15%)

USD 5.76B
UPRO ProShares UltraPro S&P500

+2.57 (+3.13%)

USD 4.34B
TECL Direxion Daily Technology Bull..

+2.97 (+4.17%)

USD 3.09B
YINN Direxion Daily FTSE China Bull..

+5.93 (+14.77%)

USD 1.89B
USD ProShares Ultra Semiconductors

+1.39 (+2.93%)

USD 1.16B
UDOW ProShares UltraPro Dow30

+3.00 (+3.24%)

USD 0.77B
LABU Direxion Daily S&P Biotech Bul..

+4.28 (+5.72%)

USD 0.77B

ETFs Containing PILL

N/A

Market Performance

  Market Performance vs. Industry/Classification (Trading--Leveraged Equity) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 4.93% 60% D- 78% C+
Dividend Return N/A N/A N/A N/A N/A
Total Return 4.93% 60% D- 77% C+
Trailing 12 Months  
Capital Gain -14.76% 24% F 16% F
Dividend Return 0.89% 44% F 13% F
Total Return -13.87% 23% F 15% F
Trailing 5 Years  
Capital Gain -57.46% 17% F 7% C-
Dividend Return 1.60% 16% F 4% F
Total Return -55.86% 15% F 6% D-
Average Annual (5 Year Horizon)  
Capital Gain 56.93% 79% B- 95% A
Dividend Return 57.53% 79% B- 94% A
Total Return 0.59% 41% F 15% F
Risk Return Profile  
Volatility (Standard Deviation) 393.01% 15% F 3% F
Risk Adjusted Return 14.64% 27% F 30% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
High dividend returns

The stock has outperformed its sector peers on average annual dividend returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile. This can be a good buy, especially if it is outperforming on total return basis , for investors seeking high income yields.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.